ARID1A and rectal cancer: Since mutations in ARID1A have been shown to lead to the loss of protein expression in tumors [25, 36–38], we next examined the frequency of the loss of ARID1A protein expression by immunohistochemical analysis of tissue microarrays from treatment naïve rectal cancer patients.